QPS Holdings, LLC announced the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials. The adoption of the Oracle Argus drug safety platform underscores QPS's commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients' clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS' ability to capture, manage, and report adverse events in accordance with global regulatory requirements. The deployment of Oracle Argus will enable QPS to: Support clients with best-in-class safety monitoring solutions; Enhance oversight and traceability across all phases of clinical trials; Streamline pharmacovigilance workflows and safety case management; Improve efficiency in regulatory reporting for global submissions.